G9210 – Hepatitis c quantitative rna testing not performed between 4-12 weeks after the initiation of antiviral treatment for documented reason(s) (e.g., patients whose treatment was discontinued during the testing period prior to testing, other medical reasons, patient declined, other patient reasons)
HCPCS Level II code · G codes: Procedures / Professional Services (Temporary)
HCPCS codeG9210
- Long description
- Hepatitis c quantitative rna testing not performed between 4-12 weeks after the initiation of antiviral treatment for documented reason(s) (e.g., patients whose treatment was discontinued during the testing period prior to testing, other medical reasons, patient declined, other patient reasons)
- Short description
- No hepc rna after med docrsn
- Pricing indicator
00Not separately priced by Part B (bundled, not covered or Part A only)- Medicare coverage
CCarrier judgment – coverage decided by the Medicare contractor- BETOS category
M5BSpecialist - psychiatry- Added
- January 1, 2014
- Last change
- January 1, 2017 – No change
- Termination date
- December 31, 2016
Frequently asked questions
What is HCPCS code G9210?
G9210 is a HCPCS Level II code for hepatitis c quantitative rna testing not performed between 4-12 weeks after the initiation of antiviral treatment for documented reason(s) (e.g., patients whose treatment was discontinued during the testing period prior to testing, other medical reasons, patient declined, other patient reasons). It was discontinued on December 31, 2016.
Does Medicare cover G9210?
The HCPCS file lists coverage code C: Carrier judgment – coverage decided by the Medicare contractor. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby G codes
- G9202 – Patients with a positive hepatitis c antibody test
- G9203 – Rna testing for hepatitis c documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c
- G9204 – Rna testing for hepatitis c was not documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c, reason not given
- G9205 – Patient starting antiviral treatmentfor hepatitis c during the measurement period
- G9206 – Patient starting antiviral treatment for hepatitis c during the measurement period
- G9207 – Hepatitis c genotype testing documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c
- G9208 – Hepatitis c genotype testing was not documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c, reason not given
- G9209 – Hepatitis c quantitative rna testing documented as performed between 4-12 weeks after the initiation of antiviral treatment
- G9211 – Hepatitis c quantitative rna testing was not documented as performed between 4-12 weeks after the initiation of antiviral treatment, reason not given
- G9212 – Dsm-ivtm criteria for major depressive disorder documented at the initial evaluation
- G9213 – Dsm-iv-tr criteria for major depressive disorder not documented at the initial evaluation, reason not otherwise specified
- G9214 – Cd4+ cell count or cd4+ cell percentage results documented
- G9215 – Cd4+ cell count or percentage not documented as performed, reason not given
- G9216 – Pcp prophylaxis was not prescribed at time of diagnosis of hiv, reason not given
- G9217 – Pcp prophylaxis was not prescribed within 3 months of low cd4+ cell count below 200 cells/mm3, reason not given
- G9218 – Pcp prophylaxis was not prescribed within 3 months oflow cd4+ cell count below 500 cells/mm3 or a cd4 percentage below 15%, reason not given
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.